Health Technology · Pharmaceuticals: Major · NSE: MEDICO · data 2026-10-09
Medico Remedies Ltd.
Health check: Strong (6.8/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹22.8
Market cap
₹182 cr
P/E
13.7
P/B
—
ROE
19.0%
ROCE
20.4%
Debt / equity
0.26
Dividend yield
0.00%
1-year return
-55.3%
52-week high
₹56.88
52-week low
₹20.47
Operating margin
6.1%
Growth
| Revenue (last 12 months) | ₹238 cr |
| Net profit (last 12 months) | ₹14 cr |
| Sales growth, 3 years (yearly) | 13.4% |
| Profit growth, 3 years (yearly) | 21.9% |
Chart patterns
- Double top — breakdown (key level ₹36.55)
Similar companies
Brooks Laboratories Limited (BROOKS) · Nectar Lifesciences Ltd. (NECLIFE) · Accretion Pharmaceuticals Ltd. (ACCPL) · Curis Lifesciences Limited (CURIS) · Bal Pharma Limited (BALPHARMA)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open MEDICO in NSE Scanner →